Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS) Peptide
MARCKS
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all MARCKS products
- MARCKS (Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EEGAAGGDPQ EAKPQEAAVA PEKPPASDET KAAEEPSKVE EKKAEEAGAS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MARCKS antibody,
Alternative Names: MARCKS control peptide, MARCKS antibody Blocking Peptide, Anti-MARCKS Blocking Peptide, myristoylated alanine-rich protein kinase C substrate Blocking Peptide, 80K-L Blocking Peptide, FLJ14368 Blocking Peptide, FLJ90045 Blocking Peptide, MACS Blocking Peptide, PKCSL Blocking Peptide, PRKCSL Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MARCKS (Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS))
- Background
- The protein encoded by this gene is a substrate for protein kinase C. It is localized to the plasma membrane and is an actin filament crosslinking protein. Phosphorylation by protein kinase C or binding to calcium-calmodulin inhibits its association with actin and with the plasma membrane, leading to its presence in the cytoplasm. The protein is thought to be involved in cell motility, phagocytosis, membrane trafficking and mitogenesis.
- Molecular Weight
- 31 kDa
-
You are here:
